US Stock futures slipped early Thursday after the S&P 500 recouped some of its losses from this week's tariff-fueled slide. S ...

The mountain town of Ruidoso must rebuild again following a record-breaking flood and a year after devastating wildfires.

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

The U.S. FDA publishes over 200 complete response letters to enhance transparency within the agency. Read more here.

The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.

The FDA has released an "initial batch" of 200 complete response letters (CRLs) in efforts to boost transparency. | The FDA has released an "initial batch" of 200 complete response letters (CRLs) in ...

Investors have long asked the FDA to share its reasons for rejecting drugs, arguing that companies can use the agency’s silence on the matter to mislead the market.

The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...

The US Food and Drug Administration has started making rejection letters that pharmaceutical companies traditionally keep ...

The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with a caveat.

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...